Cite
HARVARD Citation
Overman, M. et al. (2016). Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma. BMC cancer. 16 (1), pp. 1-11. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Overman, M. et al. (2016). Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma. BMC cancer. 16 (1), pp. 1-11. [Online].